Guinea-Bissau [clinicaltrials_resource:2d65f5236205dd23c6a8212627568fb8]
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine [clinicaltrials:NCT00126217]Impact of Exclusive Breast-Feeding in Guinea Bissau [clinicaltrials:NCT00131625]Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria [clinicaltrials:NCT00131794]Chloroquine and Amodiaquine for Treatment of Malaria in Children [clinicaltrials:NCT00137514]The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children [clinicaltrials:NCT00137553]The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau [clinicaltrials:NCT00137566]Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries? [clinicaltrials:NCT00146302]Prophylactic Antibiotics in Measles [clinicaltrials:NCT00168532]Immunology of Non-specific Effects of Vaccine [clinicaltrials:NCT00168545]clinicaltrials:NCT00168558Long-term Follow-up of Measles Antibodies [clinicaltrials:NCT00168571]Different Doses of Vitamin A and Childhood Morbidity and Mortality [clinicaltrials:NCT00168584]Vitamin A With BCG Vaccine [clinicaltrials:NCT00168597]Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine [clinicaltrials:NCT00168610]Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity [clinicaltrials:NCT00168623]Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality [clinicaltrials:NCT00168636]Non-Specific Effects of Standard Titre Measles Vaccination [clinicaltrials:NCT00168662]Prenatal Multi-micronutrient Supplementation and Pregnancy Outcome [clinicaltrials:NCT00168688]Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination [clinicaltrials:NCT00244673]Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau [clinicaltrials:NCT00426439]Perinatal Hypothermia, Risk Factors and Long-Term Consequences in Guinea-Bissau, Westafrica [clinicaltrials:NCT00429000]Improved Management and in-Hospital Mortality [clinicaltrials:NCT00465777]Impact of the WHO Recommended Vitamin A Supplementation at Immunisation Contacts [clinicaltrials:NCT00514891]Sex-Differential Health Interventions In Low-Birth-Weight Infants [clinicaltrials:NCT00625482]Evaluation of Local Mechanisms for Staff Motivation to Reduce Hospital Mortality [clinicaltrials:NCT00673166]Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth [clinicaltrials:NCT00710983]Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2 [clinicaltrials:NCT01133314]clinicaltrials:NCT01141205Artemether-Lumefantrine Effectiveness in Guinea-Bissau [clinicaltrials:NCT01157689]PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial [clinicaltrials:NCT01192035]The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age [clinicaltrials:NCT01306006]Bacille Calmette-Guérin (BCG) Vaccine and Atopy [clinicaltrials:NCT01420705]Additional Measles Vaccine at 4 Months of Age [clinicaltrials:NCT01486355]clinicaltrials:NCT01644721clinicaltrials:NCT01704508Vitamin A Supplementation at Birth and Atopy in Childhood [clinicaltrials:NCT01779180]Pharmacokinetic Study of Multi-dose Chloroquine [clinicaltrials:NCT01814423]A Randomized Trial of Providing BCG Vaccination Immediately [clinicaltrials:NCT01989026]clinicaltrials:NCT02447536
country [clinicaltrials_vocabulary:country]
Guinea-Bissau [clinicaltrials_resource:2d65f5236205dd23c6a8212627568fb8]
Bio2RDF identifier
2d65f5236205dd23c6a8212627568fb8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2d65f5236205dd23c6a8212627568fb8
identifier
clinicaltrials_resource:2d65f5236205dd23c6a8212627568fb8
title
Guinea-Bissau
@en
type
label
Guinea-Bissau [clinicaltrials_resource:2d65f5236205dd23c6a8212627568fb8]
@en